Contrast developer Guerbet has received a contract for its SeQure and DraKon embolization microcatheters from group purchasing organization Premier.
First introduced in 2018, SeQure and DraKon are designed for infusion of therapeutic agents, contrast media, and embolics into peripheral vessels, according to the company.
